Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study
Erberto Carluccio, Frank Lloyd Dini, Roberto Bitto, Michele Ciccarelli, Michele Correale, Andreina D’Agostino, Giuseppe Dattilo, Marco Ferretti, Arianna Grelli, Stefania Guida, Francesca Jacoangeli, Laura Lupi, Lorenzo Luschi, Daniele Masarone, Valentina Mercurio, Giuseppe Pacileo, Nicola Riccardo Pugliese, Antonella Rispoli, Laura Scelsi, Carlo G. Tocchetti, Natale Daniele Brunetti, Alberto Palazzuoli, Massimo Piepoli, Savina Nodari, Giuseppe Ambrosio
Topics & Concepts
MedicineSacubitril, ValsartanEjection fractionCardiologyHeart failureValsartanInternal medicineSacubitrilHemodynamicsHeart failure with preserved ejection fractionBlood pressureHeart Failure Treatment and ManagementCardiovascular Function and Risk FactorsCardiac pacing and defibrillation studies